Loading provider…
Loading provider…
Hematology & Oncology Physician in Minneapolis, MN
NPI: 1427068618Primary Practice Location
MERCY HOSPITAL
4050 Coon Rapids Blvd Nw, Coon Rapids, MN
Primary Employer
Minnesota Oncology Hematology, PA
mnoncology.com
HQ Phone
Get M.D. Thomas's Phone Numberphone_androidMobile
Get M.D. Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
MN State Medical License
1992 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Yale School of Medicine
medicine.yale.edu
Medical School
Until 1978
California Institute of Technology
Post-Doctoral Fellowship • Biology
1985 - 1992
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
1982 - 1985
UCSF Health
1978 - 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 82 | 120 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 63 | 146 |
| 3 | 96413Infusion of chemotherapy into a vein up to 1 hour | 55 | 85 |
| 4 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 55 | 129 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 45 | 59 |
Authors: Martin Mccarter
Journal: J Clin Oncol
Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation.
Authors: Harold Koeffler
Journal: Blood
Lead Sponsor: Pfizer
Intervention / Treatment: DRUG: Dacarbazine, DRUG: MEK162
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: carboplatin, DRUG: paclitaxel albumin-stabilized nanoparticle formulation